Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers

European Journal of Pharmaceutical Sciences

Volumn 6, Issue 1, 1998, Pages 27-37

  Hermann, Robert ^a   Wildgrube, H Jörg ^b   Ruus, Peter ^a   Niebch, Georg ^a   Nowak, Horst ^a   Gleiter, Christoph H ^c  

^a ASTA MEDICA AG   (Germany)

^b Institute for Applied Diagnostics   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Lipoic acid; Autonomic neuropathy; Bioavailability; Diabetic neuropathy; Gastric emptying; Thioctic acid

Indexed keywords

THIOCTIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ENANTIOMER; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; STOMACH MOTILITY;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GASTRIC EMPTYING; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; STEREOISOMERISM; THIOCTIC ACID; VITAMIN B COMPLEX;

EID: 0031963189     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00065-1     Document Type: Article

References (46)

1. Atkinson M., Hosking D.J. Gastrointestinal complications of diabetes mellitus. Clin. Gastroenterol. 12:1983;633-650.
2. Bateman D.N., Whittingham T.A. Measurement of gastric emptying by real-time ultrasound. Gut. 23:1982;524-827.
3. Busse E., Zimmer G., Schopohl B., Kornhuber B. Influence of α-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneim-Forsch. Drug Res. 42:1992;829-831.
4. Buyschaert M., Moulart M., Urbain J.L., Pauwels S., De Roy L., Ketelslegers J.M., et al. Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy. Diabetes Care. 10:1987;448-452.
5. Campbell I.W., Heading R.C., Tothill P., Buist T.A.S., Ewingt D.J., Clarke B.F. Gastric emptying in diabetic autonomic neuropathy. Gut. 18:1977;462-467.
6. Elashoff J.D., Reedy T.J., Meyer H.J. Analysis of gastric emptying data. Gastroenterology. 83:1982;1306-1312.
7. Estrada D.E., Ramlal T., Klip A. Differential effect of thioctic acid isomers on glucose uptake and glucose transporters in muscle cells. Diabetologia. 37:1994;A125. [Suppl 1].
8. Ewing D.J., Clarke B.F. Diagnosis and management of diabetic autonomic neuropathy. Br. Med. J. 285:1982;916-918.
9. Ewing J., Clarke B.F. Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care. 9:1986;648-665.
10. Feldman M., Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann. Intern. Med. 98:1983;378-384.
11. Graf H., Henning H.J., Stange K. Formeln und Tabellen der mathematischen Statistik. 1966;Springer Verlag, Berlin; Heidelberg, New York.
12. Hebbard G.S., Sun W.M., Bochner F., Horowitz M. Pharmacokinetic considerations in gastrointestinal motor disorders. Clin. Pharmacokinet. 28:(1):1995;41-66.
13. Hermann R., Niebch G., Borbe H.O., Fieger H., Ruus P., Nowak H., et al. Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. Eur. J. Pharm. Sci. 4:1996;167-174.
14. Henriksen E.J., Jacob S., Tritschler H.J., Wessel K., Augustin H.J., Dietze G.J. Effects of stereoisomers of thioctic acid on glucose transport in insulin-resistant rat muscle. Diabetologia. 37:1994;A59. [Suppl. 1].
15. Holt S., McDicken W.N., Anderson T., Stewart I.C., Heading R.C. Dynamic imaging of the stomach by real-time ultrasound - a method for the study of gastric motility. Gut. 21:1980;597-601.
16. Holt S., Cervantes J., Wilkinson A.A., Wallace J.H.K. Measuring of gastric emptying rate in humans by real-time ultrasound. Gastroenterology. 90:1986;918-923.
17. Horowitz M., Harding P.E., Maddox A., Maddern G.J., Collins P.J., Chatterton B.E., et al. Gastric and oesophageal emptying in insulin-dependent diabetes mellitus. J. Gastroenterol. Hepatol. 1:1986;97-113.
18. Horowitz M., Harding P.E., Maddox A.F., Wishart J.M., Akkermans L.M.A., Chatterton B.E., et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 32:1989;151-159.
19. Irvine E.J., Tougas G., Lappalainen R., Bathurst N.C. Reliability and interobserver variability of ultrasonographic measurement of gastric emptying rate. Dig. Dis. Sci. 38:1993;803-810.
20. Kawabata T., Packer L. α-Lipoate can protect against glycation of serum albumin, but not low density lipoprotein. Biochem. Biophys. Res. Commun. 203:1994;99-104.
21. Keshavarzian A., Iber F.L., Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am. J. Gastroenterol. 82:1987;29-35.
22. Keshavarzian A., Iber F.J. Gastrointestinal involvement in insulin-requiring diabetes mellitus. J. Clin. Gastroenterol. 9:1987;685-692.
23. Levine R.R. Factors affecting gastrointestinal absorption of drugs. Am. J. Dig. Dis. 15:1970;171-188.
24. Maesaka H., Komiya K., Misugi K., Tada K. Hyperalaninemia, hyperpyruvicemia and lactic acidosis due to pyruvate carboxylase deficiency of the liver; treatment with thiamine and lipoic acid. Eur. J. Pediatr. 122:1976;159-168.
25. Matalon R., Stumpf D.A., Michals K., Hart R.D., Parks J.K., Goodman S.I. Lipoamide dehydrogenase deficiency with primary lactic acidosis: Favorable response to treatment with oral lipoic acid. J. Pediatr. 104:1984;65-69.
26. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., et al. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
27. Niebch G., Büchele B., Blome J., Grieb S., Brandt G., Kampa P., et al. Enantioselective high-performance liquid chromatography assay of (+)R- and (-)S-α-lipoic acid in human plasma. Chirality. 9:1997;32-36.
28. Nimmo W.S. Drugs, diseases and altered gastric emptying. Clin. Pharmacokinet. 1:1976;189-203.
29. Ou P., Tritschler H.J., Wolff S.P. Thioctic (lipoic) acid: a therapeutic metal chelating antioxidant? Biochem. Pharmacol. 50:1995;123-126.
30. 14C]rac-α-lipoic acid from in situ ligated segments of the gastrointestinal tract of the rat. Arzneim-Forsch. Drug Res. 45:1995;293-299.
31. Prescott L.F. Gastric emptying and drug absorption. Br. J. Clin. Pharmacol. 1:1974;189-190.
32. Prescott L.F. Gastrointestinal absorption of drugs. Med. Clin. North. Am. 58:1974;907-916.
33. Riley S.A., Sutcliffe F., Kim M., Kapas M., Rowland M., Turnberg L.A. The influence of gastrointestinal transit on drug absorption in healthy volunteers. Br. J. Clin. Pharmacol. 34:1992;32-39.
34. Sachse G., Willms B. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Horm. Metab. Res. 9:1980;105-107.
35. Soler N. Diabetic gastroparesis without autonomic neuropathy (Letter). Diabetes Care. 3:1980;201-202.
36. Suzuki Y.J., Tsuchiya M., Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic. Res. Commun. 15:1991;255-263.
37. Suzuki Y.J., Aggarwal B.B., Packer L. α-Lipoic acid is a potent inhibitor of NF-KB activation in human T cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
38. Suzuki Y.J., Tsuchiya M., Packer L. Lipoate prevents glucose-induced protein modifications. Free Rad. Res. Commun. 17:1992;211-217.
39. Tympner F., Rösch W. Gastric emptying time studies by ultrasonography. Ultraschall. 3:1982;15-17.
40. Tympner F. Ultrasonographic study of the effect of gastrokinetic drugs on gastric emptying time. Prog. Med. 43:1987;51-55. (Suppl. 1).
41. Wedmann B., Schaffstein J., Wegener M., Schmidt G., Coenen C., Ricken D. Sonographische Erfassung der Magenentleerung. Reliabilität und Validität der Antrumflächenmethode für Flüssigkeiten. Z. Gastroenterol. 28:1990;448-452.
42. Yang R., Arem R., Chan L. Gastrointestinal tract complications of diabetes mellitus. Pathophysiology and Management. Arch. Intern. Med. 144:1984;1251-1256.
43. Young M.J., Boulton A.J.M., Macleod A.F., Williams D.R.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 36:1993;150-154.
44. Ziegler D., Mayer P., Mühlen H., Gries F.A. Effekte einer Therapie mit Alpha-Liponsäure gegenüber Vitamin B1 bei der diabetischen Neuropathie. Diabetes Stoffw. 6:1993;443-448.
45. Ziegler D., Hanefeld M., Ruhnau K.J., Meißner H.P., Lobisch M., Schütte K., et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. Diabetologia. 38:1995;1425-1433.
46. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., Reichel G. Effects of treatment with the antioxidant α-Lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care. 20:1997;369-373.